Increase in endothelin B receptor expression in optic nerve astrocytes in endothelin-1 induced chronic experimental optic neuropathy

Experimental Eye Research

Volumn 88, Issue 3, 2009, Pages 378-385

  Wang, Xu ^a,b   LeVatte, Terry L ^a,b   Archibald, Michele L ^a,b   Chauhan, Balwantray C ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

astrocytes; endothelin B receptor (ETB); endothelin 1 (ET 1); optic nerve; retina ganglion cells (RGCs)

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; FLUOROCHROME; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL SURVIVAL; CHRONIC DISEASE; CONTROLLED STUDY; DENSITOMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; OPTIC NERVE DISEASE; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RETINA GANGLION CELL; SUPERIOR COLLICULUS; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; CELL SURVIVAL; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MICROSCOPY, CONFOCAL; OPTIC NERVE; OPTIC NERVE DISEASES; RATS; RATS, INBRED BN; RECEPTOR, ENDOTHELIN B; RETINAL GANGLION CELLS;

EID: 61549106296     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.09.009     Document Type: Article

References (51)

1. Agapova O.A., Kaufman P.L., Lucarelli M.J., Gabelt B.T., and Hernandez M.R. Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res. 967 (2003) 132-143
2. Agapova O.A., Ricard C.S., Salvador-Silva M., and Hernandez M.R. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 33 (2001) 205-216
3. Amiri F., Virdis A., Neves M.F., Iglarz M., Seidah N.G., Touyz R.M., Reudelhuber T.L., and Schiffrin E.L. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 110 (2004) 2233-2240
4. Burgoyne C.F., Downs J.C., Bellezza A.J., Suh J.K., and Hart R.T. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog. Retin Eye Res. 24 (2005) 39-73
5. Cellini M., Possati G.L., Profazio V., Sbrocca M., Caramazza N., and Caramazza R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol. Scand. Suppl. (1997) 11-13
6. Chauhan B.C., LeVatte T.L., Jollimore C.A., Yu P.K., Reitsamer H.A., Kelly M.E., Yu D.Y., Tremblay F., and Archibald M.L. Model of endothelin-1-induced chronic optic neuropathy in rat. Investig. Ophthalmol. Vis. Sci. 45 (2004) 144-152
7. Cioffi G.A., and Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur. J. Ophthalmol. 9 Suppl. 1 (1999) S34-S36
8. Cioffi G.A., Wang L., Fortune B., Cull G., Dong J., Bui B., and Van Buskirk E.M. Chronic ischemia induces regional axonal damage in experimental primate optic neuropathy. Arch. Ophthalmol. 122 (2004) 1517-1525
9. Deng D., Evans T., Mukherjee K., Downey D., and Chakrabarti S. Diabetes-induced vascular dysfunction in the retina: role of endothelins. Diabetologia 42 (1999) 1228-1234
10. Fagan S.C., Hess D.C., Hohnadel E.J., Pollock D.M., and Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke 35 (2004) 2220-2225
11. He S., Prasanna G., and Yorio T. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Investig. Ophthalmol. Vis. Sci. 48 (2007) 3737-3745
12. Hernandez M.R., Igoe F., and Neufeld A.H. Extracellular matrix of the human optic nerve head. Am. J. Ophthalmol. 102 (1986) 139-148
13. Hirata Y., Hayakawa H., Suzuki E., Kimura K., Kikuchi K., Nagano T., Hirobe M., and Omata M. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Circulation 91 (1995) 1229-1235
14. Koliakos G.G., Konstas A.G., Schlotzer-Schrehardt U., Hollo G., Mitova D., Kovatchev D., Maloutas S., and Georgiadis N. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br. J. Ophthalmol. 88 (2004) 523-527
15. Liu B., and Neufeld A.H. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia 30 (2000) 178-186
16. Liu B., and Neufeld A.H. Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro. Arch. Ophthalmol. 119 (2001) 240-245
17. MacCumber M.W., and D'Anna S.A. Endothelin receptor-binding subtypes in the human retina and choroid. Arch. Ophthalmol. 112 (1994) 1231-1235
18. Masaki T., Yanagisawa M., and Goto K. Physiology and pharmacology of endothelins. Med. Res. Rev. 12 (1992) 391-421
19. Morrison J.C., L'Hernault N.L., Jerdan J.A., and Quigley H.A. Ultrastructural location of extracellular matrix components in the optic nerve head. Arch. Ophthalmol. 107 (1989) 123-129
20. Neufeld A.H., Hernandez M.R., and Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol. 115 (1997) 497-503
21. Nicolela M.T., Ferrier S.N., Morrison C.A., Archibald M.L., LeVatte T.L., Wallace K., Chauhan B.C., and LeBlanc R.P. Effects of cold-induced vasospasm in glaucoma: the role of endothelin-1. Investig. Ophthalmol. Vis. Sci. 44 (2003) 2565-2572
22. Noske W., Hensen J., and Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch. Clin. Exp. Ophthalmol. 235 (1997) 551-552
23. Orgul S., Cioffi G.A., Bacon D.R., and Van Buskirk E.M. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J. Glaucoma. 5 (1996) 135-138
24. Plato C.F., Pollock D.M., and Garvin J.L. Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release. Am. J. Physiol. Renal. Physiol. 279 (2000) F326-F333
25. Prasanna G., Hulet C., Desai D., Krishnamoorthy R.R., Narayan S., Brun A.M., Suburo A.M., and Yorio T. Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma. Pharmacol. Res. 51 (2005) 41-50
26. Prasanna G., Krishnamoorthy R., Clark A.F., Wordinger R.J., and Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Investig. Ophthalmol. Vis. Sci. 43 (2002) 2704-2713
27. Prasanna G., Narayan S., Krishnamoorthy R.R., and Yorio T. Eyeing endothelins: a cellular perspective. Mol. Cell Biochem. 253 (2003) 71-88
28. Quigley H.A. Neuronal death in glaucoma. Prog. Retin Eye Res. 18 (1999) 39-57
29. Rao V.R., Krishnamoorthy R.R., and Yorio T. Endothelin-1, endothelin A and B receptor expression and their pharmacological properties in GFAP negative human lamina cribrosa cells. Exp. Eye Res. 84 (2007) 1115-1124
30. Rao V.R., Krishnamoorthy R.R., and Yorio T. Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa. Exp Eye Res. (2008)
31. Rogers S.D., Demaster E., Catton M., Ghilardi J.R., Levin L.A., Maggio J.E., and Mantyh P.W. Expression of endothelin-B receptors by glia in vivo is increased after CNS injury in rats, rabbits, and humans. Exp. Neurol. 145 (1997) 180-195
32. Rogers S.D., Peters C.M., Pomonis J.D., Hagiwara H., Ghilardi J.R., and Mantyh P.W. Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. Glia 41 (2003) 180-190
33. Roldan-Pallares M., Rollin R., Martinez-Montero J.C., Fernandez-Cruz A., Bravo-Llata C., and Fernandez-Durango R. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Retina 27 (2007) 222-235
34. Rubanyi G.M., and Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46 (1994) 325-415
35. Shareef S., Sawada A., and Neufeld A.H. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Investig. Ophthalmol. Vis. Sci. 40 (1999) 2884-2891
36. Stokely M.E., Brady S.T., and Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Investig. Ophthalmol. Vis. Sci. 43 (2002) 3223-3230
37. Stokely M.E., Yorio T., and King M.A. Endothelin-1 modulates anterograde fast axonal transport in the central nervous system. J. Neurosci. Res. 79 (2005) 598-607
38. Takahashi K., Suda K., Lam H.C., Ghatei M.A., and Bloom S.R. Endothelin-like immunoreactivity in rat models of diabetes mellitus. J. Endocrinol. 130 (1991) 123-127
39. Tengroth B., Rehnberg M., and Amitzboll T. A comparative analysis of the collagen type and distribution in the trabecular meshwork, sclera, lamina cribrosa and the optic nerve in the human eye. Acta Ophthalmol. Suppl. 173 (1985) 91-93
40. Tezel G., Kass M.A., Kolker A.E., Becker B., and Wax M.B. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J. Glaucoma. 6 (1997) 83-89
41. Torbidoni V., Iribarne M., Ogawa L., Prasanna G., and Suburo A.M. Endothelin-1 and endothelin receptors in light-induced retinal degeneration. Exp. Eye Res. 81 (2005) 265-275
42. Torbidoni V., Iribarne M., and Suburo A.M. Endothelin receptors in light-induced retinal degeneration. Exp. Biol. Med. (Maywood) 231 (2006) 1095-1100
43. Toyo-oka T., Aizawa T., Suzuki N., Hirata Y., Miyauchi T., Shin W.S., Yanagisawa M., Masaki T., and Sugimoto T. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83 (1991) 476-483
44. Trivino A., Ramirez J.M., Salazar J.J., Ramirez A.I., and Garcia-Sanchez J. Immunohistochemical study of human optic nerve head astroglia. Vision Res. 36 (1996) 2015-2028
45. Vidal L., Diaz F., Villena A., Moreno M., Campos J.G., and de Vargas I.P. Nitric oxide synthase in retina and optic nerve head of rat with increased intraocular pressure and effect of timolol. Brain Res. Bull. 70 (2006) 406-413
46. Vollmar A.M. Endothelins. Zentralbl Veterinarmed A 39 (1992) 481-493
47. Wang L., Fortune B., Cull G., Dong J., and Cioffi G.A. Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage. Arch. Ophthalmol. 124 (2006) 717-724
48. Wang X., Baldridge W.H., and Chauhan B.C. Acute endothelin-1 application induces reversible fast axonal transport blockade in adult rat optic nerve. Investig. Ophthalmol. Vis. Sci. 49 (2008) 961-967
49. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
50. Yang Z., Quigley H.A., Pease M.E., Yang Y., Qian J., Valenta D., and Zack D.J. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Investig. Ophthalmol. Vis. Sci. 48 (2007) 5539-5548
51. Zimmermann M. Endothelin in cerebral vasospasm. Clinical and experimental results. J. Neurosurg. Sci. 41 (1997) 139-151